LON:CIR Circassia Group (CIR) Share Price, News & Analysis → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free CIR Stock Alerts GBX 34 -2.50 (-6.85%) (As of 09/2/2022) Add Compare Share Share Today's Range 33.75▼ 34.9050-Day Range 34▼ 3452-Week Range 29▼ 49.95Volume4,513 shsAverage Volume773,465 shsMarket Capitalization£142.66 millionP/E Ratio3,400.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Circassia Group alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About Circassia Group Stock (LON:CIR)Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.Read More CIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CIR Stock News HeadlinesOctober 5, 2023 | finance.yahoo.comCircassia Group PLC (82C.SG)October 3, 2023 | msn.comDiscovering the Secrets of Da Vinci: Surprising Discovery About His Mother Unearthed in Historic Florence DocumentApril 23, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...July 18, 2023 | marketwatch.comNIOX Group 1H Revenue Rose on Clinical Revenue IncreaseJuly 2, 2023 | insidermonkey.comBeyond Air, Inc. (NASDAQ:XAIR) Q4 2023 Earnings Call TranscriptJune 28, 2023 | benzinga.comGlobal Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives GrowthJune 8, 2023 | finance.yahoo.comChronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2023June 7, 2023 | marketwatch.comNIOX Group Declares 2.5p Special DividendApril 23, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...May 4, 2023 | marketwatch.comAllergy Immunotherapy Market Applications, Business Opportunities, and Strategies 2030April 13, 2023 | marketwatch.comHighlights 2028 Drug Allergy Treatments and Drugs Market: Regional Growth and New AdvancementApril 11, 2023 | fool.co.ukShould you buy Neil Woodford stock Circassia Pharmaceuticals after today’s price rise?March 17, 2023 | benzinga.comAsthma and COPD Drug Market Size Growing at 5.2% CAGR Set to Reach USD 60.3 Billion By 2032February 11, 2023 | msn.comWho are the Circassians of northern Israel?September 14, 2022 | lse.co.ukTRADING UPDATES: Epwin lifts interim payout; Anpario profit fallsSeptember 9, 2022 | barrons.comNIOX Group PLCAugust 11, 2022 | marketwatch.comCircassia Group to Seek Approval to Change Name to Niox GroupJuly 16, 2022 | marketwatch.comCircassia Group Expects to Report Swing to 1H Adjusted EbitdaJuly 14, 2022 | lse.co.ukAIM WINNERS & LOSERS: Kibo extends contract; Appreciate CEO steps downJuly 14, 2022 | lse.co.ukCircassia ups guidance as revenue rises, overhead costs slashedJuly 3, 2022 | fool.co.ukCircassia PharmaceuticalsJuly 1, 2022 | msn.comSMALL CAP MOVERS: Deltic Energy shares rise on rig contract with Shell; Oxford BioDynamics sinks as it might need further fundingJuly 1, 2022 | msn.comSMALL CAP MOVERS: Deltic Energy; Oxford BioDynamicsJune 29, 2022 | marketwatch.comCircassia to Receive $10.5 Mln After US Approval of Beyond Air's LungFit Product; Shares RiseJune 28, 2022 | seekingalpha.comBeyond Air, Inc. (XAIR) CEO Steve Lisi on Q4 2022 Results - Earnings Call TranscriptMay 12, 2022 | marketwatch.comCircassia Shares Rise as Year-To-Date Earnings Beat ViewsMay 3, 2022 | nz.finance.yahoo.comInvestors in Circassia Group (LON:CIR) have unfortunately lost 65% over the last five yearsSee More Headlines Receive CIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Circassia Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/17/2020Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:CIR CUSIPN/A CIKN/A Webwww.circassia.co.uk Phone44 1865 405 560FaxN/AEmployees111Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio3,400.00 Forward P/E Ratio35.79 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.95 Current Ratio1.83 Quick Ratio1.50 Sales & Book Value Annual Sales£27.90 million Price / Sales5.11 Cash FlowGBX 3 per share Price / Cash Flow11.33 Book ValueGBX 16 per share Price / Book2.13Miscellaneous Outstanding Shares419,578,000Free FloatN/AMarket Cap£142.66 million OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Ian Roy Johnson (Age 68)Exec. Chairman Comp: $303kMr. Michael Roy David Roller A.C.A. (Age 57)ACA, BA (Hons), CFO & Director Comp: $224kMr. Jonathan EmmsCOO & Exec. DirectorMs. Nina KatariaSr. VP Global HRMs. Sarah DuncanCompany Sec.Key Competitors4basebioLON:4BBAvacta GroupLON:AVCTTiziana Life SciencesLON:TILSVerseonLON:VSNFutura MedicalLON:FUMView All Competitors CIR Stock Analysis - Frequently Asked Questions How have CIR shares performed in 2024? Circassia Group's stock was trading at GBX 34 at the start of the year. Since then, CIR stock has increased by 0.0% and is now trading at GBX 34. View the best growth stocks for 2024 here. How were Circassia Group's earnings last quarter? Circassia Group Plc (LON:CIR) posted its quarterly earnings results on Thursday, September, 17th. The company reported ($3.00) EPS for the quarter. What other stocks do shareholders of Circassia Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Circassia Group investors own include EnQuest (ENQ), boohoo group (BHOOY), Cummins (CMI), FutureFuel (FF), Trade Desk (TTD), Ascential (ASCL), H&T Group (HAT), Howden Joinery Group (HWDN), NMC Health (NMC) and Oxford Biomedica (OXB). How do I buy shares of Circassia Group? Shares of CIR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CIR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Circassia Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
